Follow on Google News News By Tag Industry News News By Location Country(s) Industry News
Follow on Google News | Address the challenges of CNS orphan diseases and learn from real-life case studies with QCTRSMi’s CNS Orphan Diseases – the alternative route in CNS masterclass - hosted by QCTR will take place on the 8th April in London
By: SMi Group Ltd (Source: visiongain, “World Market For Orphan CNS Drugs Will Exceed $2.5BN in 2018?' , 2014) SMi's masterclass hosted by QCTR will look at the challenges and potential advantages of developing drugs in CNS orphan diseases, compared to larger CNS indications and also looks at the support that is available to drug developers in orphan diseases. It will look at case studies of drug companies who have followed this route. Key benefits to this masterclass are: • This masterclass is essential attendance for anyone who wants to understand clinical trials in a rare CNS disease • Gain timely insight into key trial design strategies • Discover the benefits of orphan disease regulations • Learn from real-life case studies of how companies have approached these challenges For more information and full programme details please visit: www.smi-online.co.uk/ End
|
|